<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date11164516.4 (espacenet)  (Federated)  (European Patent Register), 20070703
Patent/reg. no. and dateDK/EP 2359826, 20131030
Publication date20110824
Priority no. and dateEP 06116625, 20060705
EP pub. no. and date EP 2359826 20110824
Effective date
Applicant/ownerAstraZeneca AB,
SE 151 85 Södertälje, SE
Applicant ref. no.P53060DK01
InventorMarx, Degenhard,
Obere Reute 15
78345, Moos, DE,
Wollin, Stefan-Lutz,
Mälzergasse 3
88339, Bad Waldsee, DE,
Wohlsen, Andrea,
Steubenring 6
53175, Bonn, DE,
Braun, Clemens, Obere Au 7
88400 Biberach, DE
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/22 (2006.01) , A61K 31/277 (2006.01) , A61K 31/343 (2006.01) , A61K 31/352 (2006.01) , A61K 31/366 (2006.01) , A61K 31/40 (2006.01) , A61K 31/405 (2006.01) , A61K 31/437 (2006.01) , A61K 31/44 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/453 (2006.01) , A61K 31/502 (2006.01) , A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61P 11/00 (2006.01) 
TitleKombination af HMG-reduktaseinhibitor rosuvastatin med en phosphodiesterase-4-inhibitor, såsom roflumilast, roflumilast-N-oxid til behandlingen af inflammatoriske pulmonale sygdomme
Int. application no.
Int. publication no.
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact